Cite
HARVARD Citation
Ah Kioon, M. et al. (n.d.). FRI0398 Sl-401, a novel targeted therapy directed to the interleukin-3 receptor (CD123), kills plasmacytoid dendritic cells from systemic sclerosispatients. Annals of the rheumatic diseases. pp. 731-732. [Online].